Overview

  • Product namePDE6 gamma peptide

Description

  • NatureSynthetic

Associated products

Specifications

Our Abpromise guarantee covers the use of ab5864 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking

  • Purity> 95 % SDS-PAGE.

  • FormLiquid
  • Additional notes


    This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human PDE6 gamma, catalog ab5664. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (70-fold) for competitive inhibition of antibody-protein binding reactions.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

General Info

  • Alternative names
    • 5''-cyclic phosphodiesterase subunit gamma
    • CNRG_HUMAN
    • GMP-PDE gamma
    • MGC125749
    • PDE 6
    • PDE6G
    • PDEG
    • Phosphodiesterase 6G cGMP Specific
    • Phosphodiesterase 6G cGMP specific rog gamma
    • Retinal Rod Photoreceptor cGMP Phosphodiesterase gamma
    • Retinal rod rhodopsin sensitive cGMP 3' 5'vcyclic phosphodiesterase subunit gamma
    • Retinal rod rhodopsin-sensitive cGMP 3''
    • Rod cG PDE G
    • RP57
    see all
  • FunctionParticipates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones.
  • Involvement in diseaseDefects in PDE6G are the cause of retinitis pigmentosa type 57 (RP57) [MIM:613582]. RP57 is a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
  • Sequence similaritiesBelongs to the rod/cone cGMP-PDE gamma subunit family.
  • Information by UniProt

References for PDE6 gamma peptide (ab5864)

ab5864 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab5864.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"